Adele Sarcone

Dr. Adele Sarcone

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
CMCaterina Mercuri
Caterina Mercuri
GMGiovanni Marasco
Giovanni Marasco
APAlessandra De Pasquale
Alessandra De Pasquale
Dario MarasciuloDario Marasciulo
Dario Marasciulo
SSSilvio Simeone
Silvio Simeone
ASAdele Sarcone
Adele Sarcone
Background: Early cardiopulmonary resuscitation (CPR) and timely use of automated external defibrillators (AEDs) are critical determinants of survival following out-of-hospital cardiac arrest (OHCA). University students enrolled in healthcare degree programs represent a strategic target population for the dissemination of basic life support and defibrillation (BLS-D) skills. However, evidence on their level of knowledge, attitudes, and perceived preparedness remains limited in Southern Italy. Methods: A cross-sectional observational study was conducted between mid-December 2025 and 15 January 2026 among undergraduate healthcare students at the Magna Graecia University of Catanzaro (Italy). Data were collected using a structured, self-administered questionnaire assessing socio-demographic characteristics, CPR/AED knowledge, attitudes, and perceived confidence. Composite knowledge scores were calculated and categorized as poor, sufficient, good, or excellent. Statistical analyses included chi-square tests, Cramér’s V, and Spearman’s rank correlation. Results: A total of 604 students were included (mean age 24.4 ± 6.7 years; 69.9% female), of whom 46.4% reported prior BLS-D training. Knowledge levels were heterogeneous: myocardial infarction was widely recognized as a cause of cardiac arrest (81.1%), whereas recognition of non-shockable rhythms, including asystole and pulseless electrical activity, remained low (<25%). Procedural knowledge, particularly regarding the chain of survival and chest compression rate, improved with academic year and prior BLS-D training. Conversely, ventilation skills and correct AED pad placement were consistently inadequate. Attitudes toward CPR were largely positive; however, perceived confidence in performing resuscitation was moderate to low, especially in complex scenarios. More than 80% of students expressed strong interest in further training and supported mandatory BLS-D education. Conclusions: Healthcare students demonstrated favorable attitudes toward CPR but insufficient and uneven knowledge, particularly in rhythm recognition, ventilation, and AED use. Academic progression and structured BLS-D training were associated with improved competencies, although critical gaps persisted. Integrating mandatory, hands-on BLS-D training with regular refresher sessions into healthcare curricula should enhance preparedness and potentially reduce OHCA-related mortality, especially in high-risk regions such as Calabria.

28 March 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
APAlessandra De Pasquale
Alessandra De Pasquale
ASAdele Sarcone
Adele Sarcone
MCMariangela Cassadonte
Mariangela Cassadonte
IIIole Camilla Iocca
Iole Camilla Iocca
GGGABRIELLA DI GIUSEPPE
GABRIELLA DI GIUSEPPE
CPClaudia Pileggi
Claudia Pileggi
Background: Principal aims of this study were to evaluate, in frail immunocompromised patients, the willingness to receive the herpes zoster (HZ) vaccination and the impact of the in-hospital vaccination dedicated clinic on HZ vaccination adherence. Materials and methods: A non-randomized quasi-experimental intervention study was conducted in Southern Italy among immunocompromised patients. Patients enrolled in the in-hospital vaccination dedicated clinic were included in the experimental group, while the control group consisted of patients recruited in the General Practitioners clinics. Results: From April 2024 to March 2025, 369 patients were recruited, 183 of whom were included in the experimental group and 186 in the control group, The willingness to receive HZ vaccination was declared by 46.3% of subjects, and among those, 28.5% underwent vaccination. Logistic regression results showed that participants in the experimental group were significantly more likely to both declare willingness to receive vaccination (OR = 6.32; 95% CI 3.05–13.10) and to adhere to HZ vaccination (OR = 64.63; 95% CI 14.78–282.62). Conclusions: Our findings have shown that both willingness and adherence to HZ vaccination in immunocompromised subjects remain inadequate with respect to international targets and provide an effective model of integration between different professionals capable of promoting greater accessibility and adherence to HZ vaccination.

28 September 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
ASAdele Sarcone
Adele Sarcone
MDMaria Rosaria Deodato
Maria Rosaria Deodato
APAlessandra De Pasquale
Alessandra De Pasquale
CSCaterina De Sarro
Caterina De Sarro
CNCarmelo Nobile
Carmelo Nobile
CPClaudia Pileggi
Claudia Pileggi
Background: Immunocompromised patients are at heightened risk for severe COVID-19 and its complications. While vaccination is critical for this population, long-term adherence and the durability of vaccine-induced immunity remain significant public health concerns. This study aimed to evaluate the longitudinal serological response associated with hybrid immunity and to assess temporal trends in SARS-CoV-2 vaccination adherence among immunocompromised patients. Methods: A prospective observational cohort study was conducted on 170 immunocompromised patients followed longitudinally for five years at an Italian Teaching Hospital. Humoral response was assessed by quantifying IgG antibodies against the spike receptor-binding domain (RBD) of SARS-CoV-2 (anti-RBD IgG titers) at multiple time points, from baseline through the first booster dose. Vaccination uptake and reasons for vaccine refusal were monitored throughout the study period. Results: Of the 170 enrolled patients, 159 (94.1%) completed the primary three-dose schedule. Following the initial two-dose regimen, 88% of patients were classified as non- or low-responders (mean anti-RBD IgG: 84.9 BAU/mL). Administration of an additional third dose and subsequent booster markedly enhanced immunogenicity, increasing the mean anti-RBD IgG titer to 3447.5 BAU/mL, with 87.7% of patients classified as high responders post-booster. Despite favorable clinical outcomes, with no COVID-19-related deaths recorded, vaccination uptake demonstrated a significant and continuous decline, dropping from 97% during the pandemic phase to 8.3% during the 2025–2026 campaign. Primary reasons for refusal included doubts regarding vaccine efficacy (55%) and weak indications or contraindications provided by healthcare professionals (22%). Conclusions: Repeated SARS-CoV-2 vaccine doses significantly improve humoral immunity and clinical outcomes in immunocompromised individuals. However, the progressive decline in long-term vaccine uptake, driven largely by efficacy concerns and insufficient provider recommendations, poses a major public health challenge.